Custome Adeno-associated Viral Vector Production Service refers to a specialized service that provides customized production of adeno-associated viral vectors (AAV). AAVs are commonly used gene delivery tools in various fields, including gene therapy, gene editing, and gene expression regulation. This service allows researchers and pharmaceutical companies to request the production of AAV vectors tailored to their specific needs, such as specific gene sequences or modifications. The service typically involves the production, purification, and quality control of AAV vectors, following established protocols and guidelines. It may also include options for scalable production, adherence to Good Manufacturing Practice (GMP) standards for clinical applications, and customization based on specific research or therapeutic requirements.
The global market for Custom Adeno-associated Viral Vector Production Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Custom Adeno-associated Viral Vector Production Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Custom Adeno-associated Viral Vector Production Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Custom Adeno-associated Viral Vector Production Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Custom Adeno-associated Viral Vector Production Service include Esco Aster, Vector Biolabs, Syd Labs, SIRION Biotech, Biovian, AGC Biologics, SignaGen Laboratories, Takara Bio and Curia, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Custom Adeno-associated Viral Vector Production Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Custom Adeno-associated Viral Vector Production Service by region & country, by Type, and by Application.
The Custom Adeno-associated Viral Vector Production Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Adeno-associated Viral Vector Production Service.
麻豆原创 Segmentation
By Company
Esco Aster
Vector Biolabs
Syd Labs
SIRION Biotech
Biovian
AGC Biologics
SignaGen Laboratories
Takara Bio
Curia
Andelyn Biosciences
EPFL
BPS Bioscience
AMSBIO
Boster Bio
Creative Biogene
Thermo Fisher Scientific
Segment by Type:
Small-scale
Medium-scale
Large-scale
Segment by Application
Gene Therapy
Cell Therapy
Drug Research & Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Custom Adeno-associated Viral Vector Production Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Custom Adeno-associated Viral Vector Production Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Custom Adeno-associated Viral Vector Production Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Custom Adeno-associated Viral Vector Production Service Product Introduction
1.2 Global Custom Adeno-associated Viral Vector Production Service 麻豆原创 Size Forecast
1.3 Custom Adeno-associated Viral Vector Production Service 麻豆原创 Trends & Drivers
1.3.1 Custom Adeno-associated Viral Vector Production Service Industry Trends
1.3.2 Custom Adeno-associated Viral Vector Production Service 麻豆原创 Drivers & Opportunity
1.3.3 Custom Adeno-associated Viral Vector Production Service 麻豆原创 Challenges
1.3.4 Custom Adeno-associated Viral Vector Production Service 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Custom Adeno-associated Viral Vector Production Service Players Revenue Ranking (2023)
2.2 Global Custom Adeno-associated Viral Vector Production Service Revenue by Company (2019-2024)
2.3 Key Companies Custom Adeno-associated Viral Vector Production Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Custom Adeno-associated Viral Vector Production Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Custom Adeno-associated Viral Vector Production Service
2.6 Custom Adeno-associated Viral Vector Production Service 麻豆原创 Competitive Analysis
2.6.1 Custom Adeno-associated Viral Vector Production Service 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Custom Adeno-associated Viral Vector Production Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Adeno-associated Viral Vector Production Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Small-scale
3.1.2 Medium-scale
3.1.3 Large-scale
3.2 Global Custom Adeno-associated Viral Vector Production Service Sales Value by Type
3.2.1 Global Custom Adeno-associated Viral Vector Production Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Custom Adeno-associated Viral Vector Production Service Sales Value, by Type (2019-2030)
3.2.3 Global Custom Adeno-associated Viral Vector Production Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gene Therapy
4.1.2 Cell Therapy
4.1.3 Drug Research & Development
4.1.4 Others
4.2 Global Custom Adeno-associated Viral Vector Production Service Sales Value by Application
4.2.1 Global Custom Adeno-associated Viral Vector Production Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Custom Adeno-associated Viral Vector Production Service Sales Value, by Application (2019-2030)
4.2.3 Global Custom Adeno-associated Viral Vector Production Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Custom Adeno-associated Viral Vector Production Service Sales Value by Region
5.1.1 Global Custom Adeno-associated Viral Vector Production Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Custom Adeno-associated Viral Vector Production Service Sales Value by Region (2019-2024)
5.1.3 Global Custom Adeno-associated Viral Vector Production Service Sales Value by Region (2025-2030)
5.1.4 Global Custom Adeno-associated Viral Vector Production Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
5.2.2 North America Custom Adeno-associated Viral Vector Production Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
5.3.2 Europe Custom Adeno-associated Viral Vector Production Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
5.4.2 Asia Pacific Custom Adeno-associated Viral Vector Production Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
5.5.2 South America Custom Adeno-associated Viral Vector Production Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Custom Adeno-associated Viral Vector Production Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Custom Adeno-associated Viral Vector Production Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Custom Adeno-associated Viral Vector Production Service Sales Value
6.3 United States
6.3.1 United States Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
6.3.2 United States Custom Adeno-associated Viral Vector Production Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Custom Adeno-associated Viral Vector Production Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
6.4.2 Europe Custom Adeno-associated Viral Vector Production Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Custom Adeno-associated Viral Vector Production Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
6.5.2 China Custom Adeno-associated Viral Vector Production Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Custom Adeno-associated Viral Vector Production Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
6.6.2 Japan Custom Adeno-associated Viral Vector Production Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Custom Adeno-associated Viral Vector Production Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
6.7.2 South Korea Custom Adeno-associated Viral Vector Production Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Custom Adeno-associated Viral Vector Production Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
6.8.2 Southeast Asia Custom Adeno-associated Viral Vector Production Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Custom Adeno-associated Viral Vector Production Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Custom Adeno-associated Viral Vector Production Service Sales Value, 2019-2030
6.9.2 India Custom Adeno-associated Viral Vector Production Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Custom Adeno-associated Viral Vector Production Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Esco Aster
7.1.1 Esco Aster Profile
7.1.2 Esco Aster Main Business
7.1.3 Esco Aster Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.1.4 Esco Aster Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.1.5 Esco Aster Recent Developments
7.2 Vector Biolabs
7.2.1 Vector Biolabs Profile
7.2.2 Vector Biolabs Main Business
7.2.3 Vector Biolabs Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.2.4 Vector Biolabs Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.2.5 Vector Biolabs Recent Developments
7.3 Syd Labs
7.3.1 Syd Labs Profile
7.3.2 Syd Labs Main Business
7.3.3 Syd Labs Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.3.4 Syd Labs Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.3.5 SIRION Biotech Recent Developments
7.4 SIRION Biotech
7.4.1 SIRION Biotech Profile
7.4.2 SIRION Biotech Main Business
7.4.3 SIRION Biotech Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.4.4 SIRION Biotech Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.4.5 SIRION Biotech Recent Developments
7.5 Biovian
7.5.1 Biovian Profile
7.5.2 Biovian Main Business
7.5.3 Biovian Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.5.4 Biovian Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.5.5 Biovian Recent Developments
7.6 AGC Biologics
7.6.1 AGC Biologics Profile
7.6.2 AGC Biologics Main Business
7.6.3 AGC Biologics Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.6.4 AGC Biologics Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.6.5 AGC Biologics Recent Developments
7.7 SignaGen Laboratories
7.7.1 SignaGen Laboratories Profile
7.7.2 SignaGen Laboratories Main Business
7.7.3 SignaGen Laboratories Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.7.4 SignaGen Laboratories Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.7.5 SignaGen Laboratories Recent Developments
7.8 Takara Bio
7.8.1 Takara Bio Profile
7.8.2 Takara Bio Main Business
7.8.3 Takara Bio Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.8.4 Takara Bio Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.8.5 Takara Bio Recent Developments
7.9 Curia
7.9.1 Curia Profile
7.9.2 Curia Main Business
7.9.3 Curia Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.9.4 Curia Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.9.5 Curia Recent Developments
7.10 Andelyn Biosciences
7.10.1 Andelyn Biosciences Profile
7.10.2 Andelyn Biosciences Main Business
7.10.3 Andelyn Biosciences Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.10.4 Andelyn Biosciences Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.10.5 Andelyn Biosciences Recent Developments
7.11 EPFL
7.11.1 EPFL Profile
7.11.2 EPFL Main Business
7.11.3 EPFL Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.11.4 EPFL Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.11.5 EPFL Recent Developments
7.12 BPS Bioscience
7.12.1 BPS Bioscience Profile
7.12.2 BPS Bioscience Main Business
7.12.3 BPS Bioscience Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.12.4 BPS Bioscience Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.12.5 BPS Bioscience Recent Developments
7.13 AMSBIO
7.13.1 AMSBIO Profile
7.13.2 AMSBIO Main Business
7.13.3 AMSBIO Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.13.4 AMSBIO Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.13.5 AMSBIO Recent Developments
7.14 Boster Bio
7.14.1 Boster Bio Profile
7.14.2 Boster Bio Main Business
7.14.3 Boster Bio Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.14.4 Boster Bio Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.14.5 Boster Bio Recent Developments
7.15 Creative Biogene
7.15.1 Creative Biogene Profile
7.15.2 Creative Biogene Main Business
7.15.3 Creative Biogene Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.15.4 Creative Biogene Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.15.5 Creative Biogene Recent Developments
7.16 Thermo Fisher Scientific
7.16.1 Thermo Fisher Scientific Profile
7.16.2 Thermo Fisher Scientific Main Business
7.16.3 Thermo Fisher Scientific Custom Adeno-associated Viral Vector Production Service Products, Services and Solutions
7.16.4 Thermo Fisher Scientific Custom Adeno-associated Viral Vector Production Service Revenue (US$ Million) & (2019-2024)
7.16.5 Thermo Fisher Scientific Recent Developments
8 Industry Chain Analysis
8.1 Custom Adeno-associated Viral Vector Production Service Industrial Chain
8.2 Custom Adeno-associated Viral Vector Production Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Custom Adeno-associated Viral Vector Production Service Sales Model
8.5.2 Sales Channel
8.5.3 Custom Adeno-associated Viral Vector Production Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Esco Aster
Vector Biolabs
Syd Labs
SIRION Biotech
Biovian
AGC Biologics
SignaGen Laboratories
Takara Bio
Curia
Andelyn Biosciences
EPFL
BPS Bioscience
AMSBIO
Boster Bio
Creative Biogene
Thermo Fisher Scientific
听
听
*If Applicable.
